Apatinib Mesylate Tablets

Product description

It is an orally bioavailable, small-molecule receptor tyrosine kinase inhibitor.

Strength: 0.25g; 0.375g; 0.425g

CFDA approved.

Read more

Specifications

Categories Finished Dosage FormsTablets; Finished Dosage Forms
Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

More products from Jiangsu Hengrui Medicine Co., Ltd.

View all our products (78)

Products from other suppliers

Apatinib Mesylate Tablets

Contact information

Address

Telephone

Website

View all contact information